BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar U, Singh S. Role of Somatostatin in the Regulation of Central and Peripheral Factors of Satiety and Obesity. Int J Mol Sci 2020;21:E2568. [PMID: 32272767 DOI: 10.3390/ijms21072568] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tomassi S, Trotta AM, Ieranò C, Merlino F, Messere A, Rea G, Santoro F, Brancaccio D, Carotenuto A, D'amore VM, Di Leva FS, Novellino E, Cosconati S, Marinelli L, Scala S, Di Maro S. Disulfide Bond Replacement with 1,4‐ and 1,5‐Disubstituted [1,2,3]‐Triazole on C‐X‐C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences. Chem Eur J 2020;26:10113-25. [DOI: 10.1002/chem.202002468] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
2 Nakamura Y, Takahashi M, Inoue Y, Yanagimoto S, Okanoya K, Koike S. Nutrient infusion evoked magnetic resonance imaging signal in the human hypothalamus. Nutr Neurosci 2021;:1-8. [PMID: 34590989 DOI: 10.1080/1028415X.2021.1983102] [Reference Citation Analysis]
3 Vishnyakova PA, Moiseev KY, Porseva VV, Pankrasheva LG, Budnik AF, Nozdrachev AD, Masliukov PM. Somatostatin-Expressing Neurons in the Tuberal Region of Rat Hypothalamus during Aging. J Evol Biochem Phys 2021;57:1480-9. [DOI: 10.1134/s0022093021060247] [Reference Citation Analysis]
4 Rogoza O, Megnis K, Kudrjavceva M, Gerina-Berzina A, Rovite V. Role of Somatostatin Signalling in Neuroendocrine Tumours. Int J Mol Sci 2022;23:1447. [PMID: 35163374 DOI: 10.3390/ijms23031447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Borsdorf B, Dahmen B, Buehren K, Dempfle A, Egberts K, Ehrlich S, Fleischhaker C, Konrad K, Schwarte R, Timmesfeld N, Wewetzer C, Biemann R, Scharke W, Herpertz-Dahlmann B, Seitz J. BDNF levels in adolescent patients with anorexia nervosa increase continuously to supranormal levels 2.5 years after first hospitalization. J Psychiatry Neurosci 2021;46:E568-78. [PMID: 34654737 DOI: 10.1503/jpn.210049] [Reference Citation Analysis]